Address: Al Hawiy St., Hitteen Dist., Riyadh , Saudi Arabia
P.O.Box: 13516
Phone: +966920019011
Mobile: +966532375500
Consultation Email: info@mesned.com
Training Email: training@mesned.com
CRO Email: cro@mesned.com
Pharmacovigilance Email: bd@mesned.com
Course Description
Learn about parameters for validating analytical procedures for small molecules based on USP-NF General Chapters <1225> Validation of Compendial Procedures and <1226> Verification of Compendial Procedures. Topics include comparing <1225> and <1226> and understanding the differences between <1225> and ICH guidelines.
There will be a knowledge assessment at the end of the course. If this course is taken as part of the USP certificate program, you will be required to pass this knowledge assessment with a score of 80 percent to determine if your comprehension of the topics presented meets USP’s minimum requirements. The live version of this recording took place on February 1, 2018.This course includes English subtitles.
Upon completion of this course, you will be able to:
Who Should Participate:
BIOGRAPHY
Principal scientific liaison at the Science Department at the United States Pharmacopeia. Scientific liaison to the USP Expert Committee on Dosage Forms working on general chapters for performance tests (dissolution/drug release), and for some pharmaceutical dosage forms (products applied to the skin, ophthalmic products, etc.), responsible for the USP general chapters on osmolality, titrimetry, and UV/Vis spectrophotometry.
Dr. Marques is also responsible for developing specifications for reagents, test solutions, buffer solutions, etc., used in USP – NF monographs. She manages the USP database on chromatographic columns, the USP database on dissolution methods and the USP web site on column equivalency. She has a B.Sc. and an M. Sc. both in Pharmacy by the University of Sao Paulo, Brazil. She has a Ph. D. in Analytical Chemistry by the State University of Campinas, Brazil. She managed analytical laboratories at Ciba-Geigy, Sandoz, and Astra.
MPCC (a member of
Bana Group) was established in 2005 and is now the healthcare industry’s FIRST
choice for sustainable outsourcing of Regulatory affairs, Clinical Research and
Technical consulting services in the Middle East.